{"SPADE_UN_19699": {"Sequence Information": {"Peptide Name": "Di PGLa-H [V5G], Kiadin-2", "Sequence": "KIAKGALKALKIAKVALKAL", "Sequence Length": 20, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "Q91826", "uniprotUrl": "http://www.uniprot.org/uniprot/Q91826", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}, {"uniprotId": "Q99134", "uniprotUrl": "http://www.uniprot.org/uniprot/Q99134", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Antibacterial Activity Affected by the Conformational Flexibility in Glycine-Lysine Based ?-Helical Antimicrobial Peptides.", "Pubmed ID": "29553266", "Reference": "J Med Chem. 2018;61:2924-2936", "Author": "Roncević T, Vukicevic D, Ilic N, Krce L, Gajski G, Tonkić M, Goić-Barisić I, Zoranić L, Sonavane Y, Benincasa M, Jureti? D, Maravic A, Tossi A", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29553266"}, {"Title": "Relating Molecular Dynamics Simulations to Functional Activity for Gly-Rich Membranolytic Helical Kiadin Peptides.", "Pubmed ID": "37242675", "Reference": "Pharmaceutics. 2023;15:1433", "Author": "Roncević T, Maleš M, Sonavane Y, Guida F, Pacor S, Tossi A, Zoranić L", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/37242675"}], "Mass": 2048.64, "PI": 10.7, "Net Charge": 6, "Hydrophobicity": 0.77, "Frequent Amino Acids": "AKL", "Absent Amino Acids": "CDEFHMNOPQRSTUWY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 13, "Polar Residues": 7, "Positive Residues": 6, "Negative Residues": 0, "SPADE ID": "SPADE_UN_19699", "Similar Sequences": [{"SPADE_ID": "SPADE_N_02003", "Similarity": 1.0, "Sequence": "KIAKVALKAL"}, {"SPADE_ID": "SPADE_N_02636", "Similarity": 1.0, "Sequence": "FDVMGIIKKIAGAL"}, {"SPADE_ID": "SPADE_UN_19699", "Similarity": 1.0, "Sequence": "KIAKGALKALKIAKVALKAL"}], "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=30±3 µM", "Target Organism": "Escherichia coli ATCC 25922(MIC=0.25-0.5µM),Escherichia coli ATCC 25922(MBC=0.5-1µM),Escherichia coli(MIC=4µM),Escherichia coli(MBC=8µM),Acinetobacter baumannii ATCC 19606(MIC=0.5-1µM),Acinetobacter baumannii ATCC 19606(MBC=1µM),Acinetobacter baumannii(MIC=0.5µM),Acinetobacter baumannii(MBC=1µM),Klebsiella pneumoniae ATCC 13883(MIC=2µM),Klebsiella pneumoniae ATCC 13883(MBC=2µM),Klebsiella pneumoniae(MIC=4µM),Klebsiella pneumoniae(MBC=8µM),Pseudomonas aeruginosa ATCC 27853(MIC=2µM),Pseudomonas aeruginosa ATCC 27853(MBC=4µM),Pseudomonas aeruginosa(MIC=2-4µM),Pseudomonas aeruginosa(MBC=4µM),Staphylococcus aureus ATCC 25923(MIC=8-16µM),Staphylococcus aureus ATCC 25923(MBC=8-16µM),Staphylococcus aureus(MIC=4-8µM),Staphylococcus aureus(MBC=8µM),Staphylococcus aureus ATCC 25923(MIC=8-16µM),Staphylococcus aureus ATCC 25923(MBC=8-16µM),Human chronic B cell leukemia MEC-1(IC50=>50µM)"}}}